MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/hem3.70159

Медицинская библиотека · HemaSphere · 2025

Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma.

Born Patrick, Fandrei David, Wang Song Yau, Perez-Fernandez Carmen, Fischer Luise, Ussmann Jule, Bach Enrica, Hoffmann Sandra, Metzeler Klaus H, Herling Marco, Herling Carmen, Jentzsch Madlen, Boldt Andreas, Seiffert Sabine, Baber Ronny, Weidner Heike, Franke Georg-Nikolaus, Denecke Timm, Sabri Osama, Platzbecker Uwe, Vucinic Vladan, Meyer Hans Jonas, Kurch Lars, Merz Maximilian

СтатьяПеревод в очереди

Аннотация

PET/CT plays an important role in staging of multiple myeloma (MM) and detecting extramedullary disease (EMD); however, its role in patients treated with commercially available CAR T cell therapies is unclear. We evaluated 61 patients treated with CAR T cell products. In 53 patients, PET/CT was available before CAR T infusion, and 43 had follow-up PET/CT on day 30. Findings from PET/CT were correlated to (CAR) T single-cell dynamics, fitness and T cell receptor diversity after infusion, and serological markers of tumor burden and inflammation. Patients with bone-independent EMD had inferior median progression-free survival (PFS: 3 vs. 15 months, p = 0.01). Univariate and multivariate analysis showed that EMD but not the number of lesions or metabolic tumor volume (MTV) were associated with inferior PFS. High MTV was connected to higher baseline sBCMA and Interleukin-6 levels, but not associated with hampered CAR T cell expansion or decreased fitness of the bystander T cell compartment. Follow-up PET/CTs identified patients with metabolic complete remissions, which were associated with better PFS. PET/CT identifies patients with high risk of relapse after CAR T cell therapy.

Для цитирования: Born Patrick, Fandrei David, Wang Song Yau, Perez-Fernandez Carmen, Fischer Luise, Ussmann Jule, Bach Enrica, Hoffmann Sandra, Metzeler Klaus H, Herling Marco, Herling Carmen, Jentzsch Madlen, Boldt Andreas, Seiffert Sabine, Baber Ronny, Weidner Heike, Franke Georg-Nikolaus, Denecke Timm, Sabri Osama, Platzbecker Uwe, Vucinic Vladan, Meyer Hans Jonas, Kurch Lars, Merz Maximilian. Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma.. HemaSphere. 2025. DOI: 10.1002/hem3.70159.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.